Trials / Active Not Recruiting
Active Not RecruitingNCT04550247
A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
A National, Prospective, Non- Interventional Study (NIS) in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma and Subsequent Treatments in Case of Relapse
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 362 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational prospective study to estimate in real world conditions the effectiveness, the safety profile and the pattern of use of adjuvant nivolumab in adults participants with stage III/IV resected melanoma, and subsequent treatments administered in case of relapse.
Conditions
Timeline
- Start date
- 2020-09-02
- Primary completion
- 2027-03-15
- Completion
- 2027-03-15
- First posted
- 2020-09-16
- Last updated
- 2022-03-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04550247. Inclusion in this directory is not an endorsement.